miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling
Main Authors: | Bhagat, T, Zhou, L, Sokol, L, Kessel, R, Caceres, G, Gundabolu, K, Tamari, R, Gordon, S, Mantzaris, I, Jodlowski, T, Yu, Y, Jing, X, Polineni, R, Bhatia, K, Pellagatti, A, Boultwood, J, Kambhampati, S, Steidl, U, Stein, C, Ju, W, Liu, G, Kenny, P, List, A, Bitzer, M, Verma, A |
---|---|
Format: | Journal article |
Published: |
2013
|
Similar Items
-
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling.
by: Bhagat, T, et al.
Published: (2013) -
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.
by: Zhou, L, et al.
Published: (2008) -
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.
by: Zhou, L, et al.
Published: (2011) -
TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients.
by: Caceres, G, et al.
Published: (2013) -
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.
by: Barreyro, L, et al.
Published: (2012)